Gabriele Antonarelli

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Gabriele Antonarelli

Nov 13, 2024, 08:27 | Insight

Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a recent…

Nov 10, 2024, 13:41 | Blog

The most recent Breast Cancer Research Digest by Dana-Farber Cancer Institute

Dana-Farber’s Breast Oncology Center shared on X: "Check out the Breast Cancer Research Digest -…

Nov 3, 2024, 15:49 | Blog

Paolo Cotzia: Investigating the role of immunotherapy in metastatic inflammatory breast cancer

Paolo Cotzia, Medical Director of Molecular Pathology and Head of Molecular Excellence at Sonic Healthcare…

Jul 19, 2023, 18:34 | Insight

In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn - Paolo Tarantino

In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023